Bangkok Dusit Medical Services Public Company Limited Depositary Receipt logo

Bangkok Dusit Medical Services Public Company Limited Depositary Receipt (TBDD)

Market Closed
13 Aug, 09:00
SGX SGX
S$
1. 52
+0.02
+1.3333%
S$
- Market Cap
- P/E Ratio
0.09% Div Yield
10,800 Volume
- Eps
S$ 1.5
Previous Close
Add Transaction
Day Range
1.51 1.52
Year Range
1.4 1.83
Want to track TBDD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Bangkok Dusit Medical Services Public Company Limited Depositary Receipt (TBDD) Statistics

Valuation metrics

Market Cap -
Enterprise value 1.31B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 5.41
Enterprise Value/Revenue 0.29
Enterprise Value/EBITDA 1.28

Overview

Shares outstanding -
Float 12.84B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 16K
Average volume (90 days) 15.75K

Price summary

52-Week low 1.4
52-Week high 1.83
Beta 0.3
50-Day moving average 1.56
200-Day moving average 1.59

Dividends and splits

Forward annual dividend rate 0.09
Forward annual dividend yield 0.0644%
Trailing annual dividend rate 0.07
Trailing annual dividend yield 0.0499%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 17 Mar 2026
Ex-Dividend Date 10 Mar 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.14%
Operating margin 0.18%

Operational effectiveness

Return on assets 0.08%
Return on equity 0.14%

Income Statement

Revenue (ttm) 4.44B
Revenue per share (ttm) 7.13
Quarterly revenue growth (yoy) 0%
Gross profit (ttm) 1.63B
EBITDA 1.03B
Net income to common (ttm) 609.66M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -0.07%

Balance Sheet

Total cash (mrq) 289.58M
Total cash per share (mrq) 0.47
Total debt (mrq) 549.4M
Total Debt/Equity (mrq) 12.27
Current ratio (mrq) 1.16%
Book value per share (mrq) 0.26

Cash Flow

Cash flow statement 867.22M
Levered free cash flow (LFCF) 283.39M